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A B S T R A C T
The ability of 59 wild-type strains of Pseudomonas aeruginosa to adhere to the HeLa
and Buffalo Green Monkey Kidney (BGMK) cells was investigated. Twenty strains were
isolated from sputa of cystic fibrosis patients, while 19 strains were isolated from trac-
heal aspirates and 20 from bronchial secretions of patients without cystic fibrosis, and
they were used as a control group of strains. The statistically significant difference be-
tween adherence ability of strains was observed (p<0.01). While most of the tracheal and
bronchial isolates were hyperadhesive (51–110 bacteria per cell) most of the cystic fibrosis
isolates adhered poorly to the HeLa and BGMK cells (1–10 bacteria per cell). The bacte-
rial binding to the cells was blocked when bacteria were incubated at 80°C for 20 min be-
fore the adherence assay. These results indicate that alginate is not involved in the adher-
ence of P. aeruginosa to the used epithelial cell lines, and, because of that, mucoid strains
isolated from persistently colonized cystic fibrosis patients showed poor adherence ability.
Key words: Pseudomonas aeruginosa, adherence, alginate, cystic fibrosis, chronic
lung infection
Introduction
Cystic fibrosis (CF) is the most com-
mon lethal genetic disease in humans1.
Most of the patients with CF are defective
in the cystic fibrosis transmembrane con-
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ductance regulator protein, which results
in altered secretion in the secretory epit-
helia2. The produced hyperviscous mucus
increases the incidence of bacterial lung
infections in CF patients. Staphylococcus
aureus is usually the first pulmonary iso-
late from these patients and together with
Haemophilus influenzae predisposes the
CF affected lung to colonization with
Pseudomonas aeruginosa. Although Bur-
kholderia cepacia has also been shown to
infect the lungs of CF patients with lethal
consequences, it has never attained the
80% colonization rate of P. aeruginosa3.
The exact mechanism of P. aeruginosa
colonization of the lungs of patients with
CF is not known4. There is evidence that
enhanced pseudomonal receptors on the
respiratory epithelia and impaired muco-
ciliary clearance may be responsible2.
During initial colonization, the bacteria
are nonmucoid. One of the most striking
and clinically important features of infec-
tion by P. aeruginosa is the tendency of
this bacterium to change to a mucoid phe-
notype, probably initiating the chronic-
-infection stage of the disease1. The mu-
coid phenotype results from bacterial
production of polysaccharide known as
alginate and plays an important role in
bacterial resistance to the host immune
response and antibiotics. Lam et al. first
observed this mucoid phenotype in post-
mortem specimens of infected lung tissue
and bronchoscopy material from infected
patients5. The mucoid material was shown
to be an acetylated random copolymer of
mannuronic acid and guluronic acid6, cor-
related to poor prognosis in CF patients7.
The bacteria are capable of colonizing the
lungs of CF patients for years due to algi-
nate overproduction and biofilm forma-
tion8,9.
The ability of P. aeruginosa to adhere
to the epithelial cells is considered the
initial step in its colonization and subse-
quent infection. This study was underta-
ken to examine the adherence ability of P.
aeruginosa strains isolated from children
with CF to two different epithelial cell
lines.
Material and Methods
Bacteria and patients: Twenty investi-
gated strains were isolated from sputa of
CF patients, while 19 strains were isola-
ted from tracheal aspirates and 20 from
bronchial secretions of patients without
cystic fibrosis, and they were used as a
control group of strains originated from
respiratory tract. Bacteria were characte-
rized biochemically as P. aeruginosa using
the API 20E System (API, Analytab Prod-
ucts, Plainview, NY). All strains were sto-
red in deep-agar tubes at +4 °C (1.5% nu-
trient agar, Difco Lab., Detroit, MI) and
were subcultured by passaging on Tryptic
Soy agar (Difco Lab., Detroit, MI) before
use. We collected P. aeruginosa isolates
from seven persistently colonized CF pa-
tients being treated at University Medi-
cal Center Zagreb from June 2000 to May
2001, aged between eight and 23 years
(mean age 13.71 years, four males and
three females). The CF patients were
chronicaly colonized with P. aeruginosa,
at least for two years (2–11 years). All
strains isolated from CF patients produ-
ced alginate and slime positivity was deter-
mined for each strain by the tube method
as described previously10. The isolates
from bronchial secretions and tracheal
aspirates were isolated in the same pe-
riod from patients without CF at Univer-
sity Hospital Osijek, which were colonized
with P. aeruginosa during their hospitali-
zation. The strains were isolated from pa-
tients hospitalized at Intensive Care Unit
(seven females and 12 males, mean age
50.21 years) and at Pulmonology Division
(four females and 16 males, mean age
58.65 years). All patients had symptoms
and signs of underlying infection, and
cultures were taken during standard di-
agnostic procedures. Slime production
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was detected in seven out of 39 strains by
the use of tube method.
Adhesion assay: Buffalo Green Mon-
key Kidney (BGMK) and HeLa, standard
continuous cell lines, were used for the
adhesion assay, which has been described
previously11. These cell lines were used
because they proved to be a good experi-
mental model for in vitro testing the ad-
herence ability of different wild-type P.
aeruginosa strains, including the isolates
originated from respiratory tract12. Brief-
ly, BGMK and HeLa cells were grown as a
monolayer in Eagle's minimal essential
medium (MEM) supplemented with 10%
heat-inactivated fetal calf serum, penicil-
lin and streptomycin in 75 cm3 cell cultu-
re flashes. When confluent, they were in-
cubated with 0.1% trypsin, washed in
MEM, and distributed into 16x125 mm
tubes containing cover slips size 12x20
mm, in which they were incubated again
at 37 °C until about 80% confluent. Mono-
layers developed on the cover slips were
washed three times in phosphate-buffe-
red saline (PBS; pH 7.2) before adherence
studies in order to remove the remains of
MEM and of antimicrobials, and dipped
into tubes containing the investigated
strain suspension in PBS adjusted to a
concentration of 1.5 x 188 bacteria/ml
(McFarland Standard, bioMerieux, Lyon,
France). After incubation lasting 1h at 37
°C with shaking (60 rpm), the cover slips
were removed from tubes and washed
thoroughly several times in PBS to elimi-
nate bacteria which did not adhere to the
cells. The cells were fixed for 15 min in
acetone and then indirect fluorescent an-
tibody test was performed. Fluorescent
staining facilitated the counting of bacte-
ria which adhered to the cells, thus avoi-
ding misinterpretation of artefacts pro-
duced by disruption of extracellular mat-
rix due to agitation. The adhesion assay
for each strain was repeated three times.
All samples were identified in code and
read by the same person.
For adhesion inhibition bacterial sus-
pensions were incubated at 80 °C for 20
min before the adhesion assay.
Statistical method: The mean adher-
ence to 40 cells for each strain constituted
the unit of observation. Statistical testing
was done with chi-square analysis with
Yeate's correction.
Results
Most strains adhered well to the used
epithelial cell lines. There was no signifi-
cant difference between adherence ability
of investigated P. aeruginosa strains to
the HeLa and to the BGMK cells (Table 1
and 2). The adherence ability of the stra-
ins was interpreted as a poor (1–10 bacte-
ria bound per cell), a good (11–50 bacteria
per cell), and a very good (more than 50
bacteria per cell).
The statistically significant difference
between adherence ability of strains iso-
lated from sputa of patients with cystic fi-
brosis and strains from tracheal aspira-
tes and bronchial secretions of patients
without cystic fibrosis was observed (p<
0.01). While most of the tracheal and
bronchial isolates were hyperadhesive
(51–110 bacteria per cell), most of the
mucoid cystic fibrosis isolates adhered
poorly to the used epithelial cell lines
(1–10 bacteria per cell; Table 1 and 2).
The bacterial binding to the cells was
almost completely blocked when hype-
radhesive bacterial strains were incuba-
ted at 80 °C for 20 min before the adhe-
sion assay (1–5 bacteria bound per 40
cells, compared with 51–110 bacteria per
cell for the untreated bacteria, depending
on strain).
Discussion
In present study, the statistically sig-
nificant difference was found between in
vitro adherence ability of P. aeruginosa
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strains isolated from respiratory tract of
patients with and without cystic fibrosis.
P. aeruginosa strains isolated from trac-
heal and bronchial aspirates of patients
without cystic fibrosis adhered signifi-
cantly better to the used epithelial cell li-
nes than mucoid strains isolated from
sputa of CF patients. The ability of bacte-
ria to adhere to mucosal surfaces of hu-
man body is considered to be a crucial
step in the pathogenesis of most infec-
tions. Attachment of P. aeruginosa to epi-
thelial cells is mediated by surface adhe-
sins. The adherence of P. aeruginosa is a
much more complex process than previ-
ously envisioned13, consisting of the inte-
ractions of multiple adhesins such as fim-
briae, exoenzime S, alginate, hemagglu-
tinin and other nonfimbrial adhesins14–19.
While the flagelar cap protein and non-
fimbrial proteinaceous adhesins of P. ae-
ruginosa are important for the initial bin-
ding of the organism to the respiratory
mucus20,21, type IV fimbriae are the most
important P. aeruginosa adhesin for bind-
ing to host cells. Numerous studies have
demonstrated a role for type IV fimbriae
in the pathogenesis of P. aeruginosa infec-
tion, particularly in the CF lung22,23. As a
further indication of their role in infec-
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TABLE 1










Sputa 15 25.42 4 6.78 1 1.70 20 33.90
Tracheal aspirates 3 5.08 4 6.78 12 20.34 19 32.20
Bronchial aspirates 1 1.70 6 10.17 13 22.03 20 33.90
Total 19 32.20 14 23.73 26 44.07 59 100.00
2 = 28.55, p<0.01
Poor adherence ability = 1–10 bacteria/cell; Good adherence ability = 11–50 bacteria/cell; Very
good adherence ability = 51–110 bacteria/cell
* Sputa were collected from patients with cystic fibrosis, and tracheal aspirates and bronchial sec-
retions from patients without cystic fibrosis
TABLE 2










Sputa 16 27.12 3 5.08 1 1.70 20 33.90
Tracheal aspirates 4 6.78 4 6.78 11 18.64 19 32.20
Bronchial aspirates 2 3.39 6 10.17 12 20.34 20 33.90
Total 22 37.29 13 22.03 24 40.68 59 100.00
2 = 25.63, p<0.01
Poor adherence ability = 1–10 bacteria/cell; Good adherence ability = 11–50 bacteria/cell; Very
good adherence ability = 51–110 bacteria/cell
* Sputa were collected from patients with cystic fibrosis, and tracheal aspirates and bronchial sec-
retions from patients without cystic fibrosis
tion, nonfimbriated mutants have been
shown to have decreased virulence relati-
ve to their parental strains in animal mo-
dels of pulmonary infections24,25. Also, P.
aeruginosa adherence to epithelial cells
was successfully inhibited by treatment
with an antibody to a GM1 – the glycos-
phingolipid receptor for P. aeruginosa
type IV fimbriae contained within epithe-
lial cell membranes26. Thus, type IV fim-
briae are considered to be factors signifi-
cant in the early stages of P. aeruginosa
chronic and acute infections. That is con-
sistent with the results of present study
and our observation that the P. aerugino-
sa strains isolated from tracheal aspira-
tes of patients hospitalized at Intensive
Care Unit and the strains isolated from
bronchial aspirates of patients without
cystic fibrosis hospitalized at Pulmonolo-
gy Division mostly adhered well to the
used cell lines (Table 1 and 2). There was
no significant difference between adhe-
rences of these strains to the HeLa and to
the BGMK cells, and based on that obser-
vation it could be concluded that both epi-
thelial cell lines express the glycosphin-
golipid receptor for P. aeruginosa. Since
the bacterial adherence to the cell was al-
most completely blocked when bacteria
were incubated at 80 °C before the adhe-
sion assay, it is obvious that alginate is
not involved in the adherence of P. aerugi-
nosa to HeLa and BGMK cells and that
proteinaceous adhesins, such as fimbriae,
are important for binding of these bacterial
strains to the epithelial cell lines. Similar
results were observed in previous study
comparing the hemagglutination and ad-
herence ability of P. aeruginosa strains
isolated from a variety of clinical sites12.
Also, we noted that the mucoid strains
isolated from persistently colonized cystic
fibrosis patients showed poor adherence
ability to the used epithelial cell lines. It
seems that proteinaceous adhesins are
important for the initial adherence of P.
aeruginosa, while alginate and biofilm
formation enable the bacteria to establish
a chronic pulmonary infection in patients
with cystic fibrosis. Recently, Hausssler
et al. identified a hyperpiliated, nonmu-
coid, small-collony variant morphotype of
P. aeruginosa isolated from respiratory
tract of cystic fibrosis patient, which exhi-
bited increased twitching motility and at-
tached strongly to the pneumocytic cell li-
ne A 54927. The emergence of these highly
adherent small-colony variants within
the cystic fibrosis lung might play a key
role in the pathogenesis of P. aeruginosa
lung infection, where a biofilm mode of
growth and a mucoid morphotype of stra-
ins are thought to be responsible for per-
sistent infection.
In summary, the results of present
study indicate that alginate is not invol-
ved in the initial adherence of P. aerugi-
nosa to the used epithelial cell lines, and,
because of that, mucoid strains isolated
from persistently colonized cystic fibrosis
patients showed poor adherence ability.
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SPOSOBNOST ADHERENCIJE NA DVIJE RAZLI^ITE EPITELNE
STANI^NE KULTURE SOJEVA PSEUDOMONAS AERUGINOSA
IZOLIRANIH U BOLESNIKA S CISTI^NOM FIBROZOM
S A @ E T A K
Istra`ena je sposobnost adherencije 59 klini~kih izolata bakterije Pseudomonas ae-
ruginosa na HeLa stani~nu kulturu i Buffalo stani~nu kulturu bubrega zelenog maj-
muna (BGMK). Dvadeset sojeva izolirano je iz iska{ljaja bolesnika oboljelih od cisti~ne
fibroze, dok je 19 sojeva izolirano iz aspirata traheje a 20 iz ispirka bronha bolesnika
koji nemaju cisti~nu fibrozu i upotrijebljeni su kao kontrolna skupina sojeva. Opa`ena
je statisti~ki zna~ajna razlika u sposobnosti adherencije istra`ivanih sojeva (p<0.01).
Dok je ve}ina trahealnih i bronhalnih izolata bila hiperadhezivna (51–110 bakterija po
stanici), ve}ina sojeva izoliranih iz iska{ljaja bolesnika oboljelih od cisti~ne fibroze sla-
bo je adherirala na HeLa i BGMK stanice (1–10 bakterija po stanici). Bakterijsko vezi-
vanje na stanice bilo je zaprije~eno kada su bakterije prije testa adherencije izlagane
temperaturi od 80 °C kroz 20 minuta. Ovi rezultati pokazuju da aginat nije uklju~en u
adherenciju bakterije P. aeruginosa na upotrijebljene stani~ne kulture, te su stoga mu-
koidni sojevi izolirani u kroni~no koloniziranih bolesnika oboljelih od cisti~ne fibroze
pokazali slabu sposobnost adherencije.
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